{"id":4664,"date":"2026-05-06T09:04:29","date_gmt":"2026-05-06T07:04:29","guid":{"rendered":"https:\/\/ksbbiotech.com\/?page_id=4664"},"modified":"2026-06-06T16:01:11","modified_gmt":"2026-06-06T14:01:11","slug":"ca199","status":"publish","type":"page","link":"https:\/\/ksbbiotech.com\/zh\/ca199\/","title":{"rendered":"\u7cd6\u7c7b\u6297\u539f19-9\uff08CA19-9\uff09"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Carbohydrate Antigen 19-9 (CA19-9)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

PDB ID: 6XTG. Source: RCSB Protein Data Bank<\/span><\/span>. For illustration purposes only.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t
\n\t\t\t\t\t

VeriGoldTM<\/sup> CA19-9<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The VeriGoldTM<\/sup> Carbohydrate Antigen 19-9 (CA19-9) Rapid Test is a chromatographic immunoassay developed for the quantitative detection of the CA19-9 tumor-associated antigen in human serum or plasma. Commonly associated pancreatic\/biliary cancers, CA19-9 serves as an important biomarker for monitoring disease activity and supporting patient management in clinical settings. The assay delivers fast and convenient results, making it suitable for point-of-care applications where timely evaluation is required.<\/p>

This test is primarily intended for the serial monitoring of patients with confirmed pancreatic cancer who present elevated CA19-9 levels at diagnosis. It may assist in assessing disease progression, treatment response, and post-therapy follow-up. Due to possible elevations in non-malignant conditions, CA19-9 results should always be interpreted together with clinical findings, imaging studies, and other laboratory data.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t